Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Club
$299/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

StageZero Life Sciences Ltd. (T:SZLS)

Business Focus: Biotechnology & Medical Research

INK Edge Outlook

Insider Chart - Past 6 Months

INK Ultra Money Free

Insider Filings

Latest 10 SEDI filings for SZLS within the last 6 months
Loading...
See all filings within the past 6 months

Company News

Oct 20, 2020 10:02 ET
StageZero Life Sciences Ltd. Announces Pricing of Public Offering
/NOT FOR DISTRIBUTION IN THE UNITED STATES OR DISSEMINATION THROUGH U.S. NEWSWIRE SERVICES/
Read full article
Oct 20, 2020 08:12 ET
IIROC Trade Resumption - SZLS
TORONTO, Oct. 20, 2020 /CNW/ - Trading resumes in:
Read full article
See more news stories

Valuation Ratios

Industry
Sector
Beta
5.70
--
--
Price to Sales - TTM
136.90
18.02
10.78
Price to Book - most recent quarter
--
4.04
2.96
Price to Cash Flow per share - TTM
25.23
13.49
11.70
Price to Free Cash Flow per share - TTM
--
48.44
20.59
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Oct 15, 202068,903-118,396
Sep 30, 2020187,299-383,511
Sep 15, 202071,351-7,856
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

StageZero Life Sciences Ltd. is a Canada-based company focused on developing and commercializing molecular diagnostic tests for early detection of cancer. It has developed Sentinel Principle platform technology, which determines biomarkers from whole blood. In additional, the Company offers ColonSentry product, it is a blood test to determine an individual's current risk for having colorectal cancer. It is developing cancer testing kit Aristotle, which is a multi-cancer panel for simultaneously screening for 10 cancers from a single sample of blood. The Company is also focused on testing Aristotle application on other disease conditions including neurology, gastroenterology, cardiology, and autoimmune disorders.

See business summary

 

Twitter

Search (past week) for $SZLS.CA

  • No tweets found